Rheumocam gains EU positive opinion
Chanelle Pharmaceuticals Manufacturing Limited (CPML)'s Rheumocam, a generic version of Vetmedica's Metacam (meloxicam), has gained a positive EU opinion on an initial marketing authorization application. It is the first small-and-medium-sized company to receive an EU opinion for a veterinary product. Rheumocam is indicated for alleviating inflammation and pain in both acute and chronic musculoskeletal disorders in dogs. CPML develops and manufactures a range of products that are no longer under patent. The company is part of Chanelle Veterinary, an Irish company set up in 1979 by Michael Burke, a veterinary surgeon.